Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice

Journal of Clinical Pathology

Volumn 59, Issue 7, 2006, Pages 740-743

  Dillon, M F ^a   Quinn, C M ^a   McDermott, E W ^a   O'Doherty, A ^a   O'Higgins, N ^a   Hill, A D K ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SIZE; CARCINOMA IN SITU; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL ASSESSMENT; PAGET NIPPLE DISEASE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURGICAL TECHNIQUE;

BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; PREOPERATIVE CARE; REOPERATION;

EID: 33745907572     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.034330     Document Type: Article

References (34)

1. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94:1546-54.
2. BreastCheck Annual report. Dublin: BreastCheck, National Breast Screening Programe, 2004/2005:21. (http://www.breastcheck.ie/publications/ evaluating-report04.pdf).
3. BreastScreen Victoria. Annual statistical report. Melbourne: BreastScreen Victoria, 2000:37-8.
4. Verkooijen HM, Peeters PHM, Buskens E, et al. Diagnostic accuracy of large core needle biopsy for nonpalpable breast disease: a meta-analysis. Br J Cancer 2000;82:1017-21.
5. Jackman JJ, Nowels KW, Rodriguez-Soto J, et al. Stereotactic, automated, large-core needle biopsy of non palpable breast lesions: false negative and histologic underestimation rates after long term follow up. Radiology 1999;210:799-805.
6. Leifland K, Lagerstedt U, Svane G, et al. Comparison of stereotactic fine needle aspiration cytology and core needle biopsy in 522 non-palpable breast lesions. Acta Radiol 2003;44:387-91.
7. Kettritz U, Rotter K, Schreer I. Stereotactic vacuum-assisted breast biopsy in 2874 patients. Cancer 2004;100:245-51.
8. Burns RB, Brown JP, Roe SM, et al. Stereotactic core-needle breast biopsy by surgeons. Ann Surg 2000;232:542-8.
9. White RR, Halperin TJ, Olsen JA, et al. Impact of core needle breast biopsy on the surgical management of mammographic abnormalities. Ann Surg 2001;233:769-77.
10. Verkooijen HM. Diagnostic accuracy of stereotactic large-core needle biopsy for nonpalpaple breast disease: results of a multicenter prospective study with 95% surgical confirmation. Int J Cancer 2002;99:853-9.
11. Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large core breast biopsy: a multi-institutional study. Radiology 1994;193:359-64.
12. Crowe JP, Rim A, Patrick RJ, et al. Does core needle biopsy accurately reflect breast pathology? Surgery 2003;134:23-8.
13. Royal College of Pathologists. NHS Cancer Screening Programmes. Guidelines for non operative diagnostic procedures and reporting in breast cancer screening, NHSBSP publication number 50. London: NHSBSP, 2001.
14. Royal College of Pathologists. NHS Cancer Screening Programmes. Pathology reporting of breast disease, NHSBSP publication number 58. London: NHSBSP, 2005.
15. Winchester DP, Jeske JM, Goldschmidt RA. The diagnosis and management of ductal carcinoma in-situ of the breast. CA Cancer J Clin 2000;50:184-200.
16. Rao A, Parker S, Ratzer E, et al. Atypical ductal hyperplasia of the breast diagnosed by 11-gauge directional vacuum-assisted biopsy. Am J Surg 2002;184:534-7.
17. Moore MM, Hargett CW III, Hanks JB, et al. Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg 1997;225:726-31.
18. Harvey JM, Sterrett GF, Frost FA. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis. Pathology 2002;34:410-6.
19. Ely KA, Carter BA, Jensen RA, et al. Core biopsy or the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 2001;25:1017-21.
20. Darling ML, Smith DN, Lester SC, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. Am J Roentgenol 2001;177:250-1.
21. Cheng MS, Fox J, Hart SA. Impact of core biopsy in the management of screen detected ductal carcinoma in situ of the breast. Ausf N Z J Surg 2003;73:404-6.
22. Pandelidis S, Heiland D, Jones D, et al. Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions. Ann Surg Oncol 2003;10:43-7.
23. Liberman L, Dershaw DD, Glassman JR, et al. Analysis of cancers not diagnosed at stereotactic core breast biopsy. Radiology 1997;203:151-7.
24. Fajardo LL, Pisano ED, Caudry DJ, et al. Stereotactic and sonographic large-core biopsy of non papable breast lesions: results of the Radiologic Diagnostic Oncology Group V Study. Acad Radiol 2004;11:293-308.
25. Leifland K, Lundquist H, Lagerstedt U, et al. Comparison of preoperative simultaneous stereotactic fine needle aspiration biopsy and stereotactic core needle biopsy in ductal carcinoma in situ of the breast. Acta Radiol 2003;44:213-7.
26. Coombs NJ, Laddie JRL, Royle GT, et al. Improving the sensitivity of stereotactic core biopsy to diagnose ductal carcinoma in situ of the breast: a mathematical model. Br J Radiol 2001;74:123-6.
27. Brenner RJ, Fajardo L, Fisher L, et al. Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. Am J Roentgenol 1996;166:341-6.
28. Liberman L, Dershaw DD, Rosen PP, et al. Sterotactic 14-gauge breast biopsy: how many core biopsy specimens are needed? Radiology 1994;192:793-5.
29. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimate rates. Radiology 2001;218:497-502.
30. Winchester DP, Bernstein JR, Jeske JM, et al. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg 2003;138:619-23.
31. Brem RF, Behrndt VS, Sanow L, et al. Atypical ductal hyperplasia: histological underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. Am J Roentgenol 1999;172:1405-7.
32. Pinder SE, Ellis IO. Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) - current definitions and classification. Breast Cancer Res 2003;5:254-7.
33. Elston CW, Sloane JP, Amendoeira I, et al. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology. Eur J Cancer 2000;36:1769-72.
34. Sloane JP, Amendoeira I, Apostolikas N, et al. Consistency achieved by 23 European pathologists form 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. Virchows Arch 1999;434:3-10.